1. Surveillance, Monitoring and Evaluation Working Group
2nd Global TB/HIV Working Group Meeting
Durban, South Africa
14-16 June 2002

2. Surveillance Information for action Ongoing Systematic
Collection, analysis, interpretation and dissemination of public health data

3. Surveillance
What?
Who?
How?

4. What to Survey? Prevalence of HIV among TB patients Smear + Smear -
Extra pulmonary TB
New TB cases
Re-treatment

5. How to Survey HIV among TB?
Systematic
Regular
Collaborative
HIV anonymous
Part of national HIV surveillance
Revisit WHO/IUATLD guidelines

6. What to Survey? TB among HIV infected people
Important for monitoring epidemic trend and intervention impact

7. How to Survey TB Among HIV?
Long term: establish a national anonymous HIV reporting system including AIDS indicator diseases
Short term: cohort studies

8. Who Should do the Surveillance?
Joint activity between the NAP and the NTP

9. Surveillance: Other Points
Quality assurance
Data feedback to service providers
Monitoring possible relation between HIV and MDR-TB

10. Monitoring and Evaluation
Monitoring X Evaluation
Monitoring activities
Evaluating outcomes
Guidelines: comprehensive set of indicators
Local prioritisation required
Review standardized data collection tool
Indicators should link to overall objectives and goals

11. Monitoring and Evaluation
Targets
Aspirational targets: difficult but inevitable
Outcome (impact on TB/HIV)
Operational targets
Measurable
Level specific: district/national/international
Informed by modelling

12. Monitoring and Evaluation
Monitoring X Evaluation
Monitoring activities
Evaluating outcomes
Guidelines: comprehensive set of indicators
Local prioritisation required